Status:
COMPLETED
Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
Lead Sponsor:
Pfizer
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This protocol describes procedures for the collection of blood samples for the intent of determining genetic contribution to the safety and efficacy of CPT/FU/LV.
Eligibility Criteria
Inclusion
- Participation in studies employing treatment with irinotecan and a signed informed consent.
Exclusion
- None.
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT00140036
Start Date
September 1 2002
End Date
August 1 2005
Last Update
March 3 2008
Active Locations (34)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Mobile, Alabama, United States, 36608
2
Pfizer Investigational Site
Tucson, Arizona, United States, 85715
3
Pfizer Investigational Site
Fresno, California, United States, 93710
4
Pfizer Investigational Site
Stamford, Connecticut, United States, 06902